Carrie Yuen is an Oncology physician affiliated with Methodist Hospital. OpenAlex indexes 49 publications with 954 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6445 Main St
Houston, TX 770301502
Telephone
713-441-9948Provider last certified this registry record 1 Jan 2026.
Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Daiichi Sankyo Inc.Program year20254 payments
- PFIZER INC.Program year20253 payments
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
38.6%Thalidomide Analog29.3%Revlimid44%Lenalidomide38%Pomalyst18%Part D<11 patientsBCL-2 Inhibitor6.8%Venclexta100%Part D<11 patients+ 1 more class in this area
Anti-infectives
35.6%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor21.5%Valacyclovir100%Part D≥26 patientsAzole Antifungal5.6%Fluconazole100%Part D<11 patients+ 2 more classes in this area
Sensory organs
11%Corticosteroid11%Dexamethasone100%Part D≥18 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Beyond the usual suspects: pelvic myeloid sarcoma imitating a gynecologic malignancy
International Journal of Gynecological Cancer
2026 - Breaking Access Barriers to Autologous Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy in Hematologic Malignancies—an ASTCT-NMDP ACCESS Initiative
Biology of Blood and Marrow Transplantation
2026 - Assessing cognitive function in transplantation and chimeric antigen receptor t cell therapy recipients: Expert recommendations from the survivorship, aging and biobehavioral special interest groups of the American Society for Transplantation and Cellular Therapy
Biology of Blood and Marrow Transplantation
2025 - Assessing physical function in transplantation and CAR-T recipients: expert recommendations from the survivorship, aging and biobehavioral special interest groups of ASTCT
Biology of Blood and Marrow Transplantation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Gerald Lawrie, MD
Methodist Hospital
Eric Peden, MD
Methodist Hospital
Randall Wolf, MD
Methodist Hospital
Jeffrey Vrabec, MD
Methodist Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”